Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01643603
Title Dasatinib in Treating Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

hematologic cancer

Therapies

Dasatinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field